(Bloomberg) -- China hawks in the US House overcame a last-ditch lobbying effort and passed legislation Monday night that would blacklist Chinese biotech companies and their US subsidiaries.
Most Read from Bloomberg
How Americans Voted Their Way Into a Housing Crisis
World's Second Tallest Tower Spurs Debate About Who Needs It
UC Berkeley Gives Transfer Students a Purpose-Built Home on Campus
